North America Diabetes Care Drugs Market to see Huge Growth by 2028
North America diabetes care drugs market is anticipated to grow significantly over the forecast period. The US and Canada are the two major economies contributing to the growth of the market. The key factor that drives the growth of the North American diabetes care drug industry includes the increased prevalence of diabetes across the region.
To Request
a Sample of our Report on North America Diabetes Care Drugs Market: https://www.omrglobal.com/request-sample/north-american-diabetes-care-drugs-market
According to IDF (International Diabetes
Federation), in 2019, the prevalence of diabetes was around 13.3% of the total
adult population in the region which is expected to increase up to 14.2% by
2030 and 15% by 2045. Thus, the increased prevalence of diabetes will create
demand for diabetes drugs and thus provides growth opportunities for the market
in the forecast period.
Further, the presence of the key players such as
Bayer AG, Bausch Health Companies Inc., Bristol Myers Squibb Co., Eli Lilly and
Co., Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S, Pfizer
Inc., among others also contributes to the growth of the market. These players
adopt several growth strategies such as product launches, mergers and
acquisitions, product innovations, and others. For instance, in February 2020,
Sun Pharmaceutical Industries through its wholly-owned subsidiary launched
Riomet ER, used to treat type 2 diabetes mellitus, in the US market. Riomet ER
is the first and only US FDA-approved liquid formulation of extended-release
metformin.
Market Coverage
·
Market number available for – 2021-2028
·
Base year- 2021
·
Forecast period- 2022-2028
·
Segment Covered- By Drug Class
·
Region Covered- North America
·
Competitive Landscape- Bausch Health Companies Inc., Bristol Myers Squibb
Co., Eli Lilly and Co., Merck & Co. Inc., Novartis International AG, Novo
Nordisk A/S, Pfizer Inc., and Takeda Pharmaceuticals Industries Ltd.
A
full Report of North America Diabetes Care Drugs Market is Available
at: https://www.omrglobal.com/industry-reports/north-american-diabetes-care-drugs-market
North America Diabetes Care Drugs Market – Segmentation
By Drug Class
·
Insulins
·
Non-Insulin Injectable Drugs
·
Oral Anti-Diabetic Drugs
·
Combination Drugs
North America Diabetes Care Drugs Market – Countries Covered
North America
·
US
·
Canada
Company Profiles
·
AstraZeneca Plc
·
Bayer AG
·
Bausch Health Companies Inc.
·
Boehringer Ingelheim International GmbH
·
Bristol Myers Squibb Co.
·
Eli Lilly and Co.
·
Johnson & Johnson Services Inc.
·
Merck & Co. Inc.
·
Mylan NV
·
Nectar Therapeutics
·
Novartis International AG
·
Novo Nordisk A/S
·
Pfizer Inc.
·
Sanofi SA
·
Sun Pharmaceutical Industries Ltd.
·
Takeda Pharmaceuticals Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment